Our broad portfolio is the foundation from which we make healthy
possible. In the US, our generics portfolio of more than 250
medicines provides affordable access to high quality medicines. Our
growing Specialty Pharma business delivers innovative products that
meet important medical needs in central nervous system disorders,
endocrinology and other therapeutic categories. And we’re working to
expand treatment options for institutions, in biosimilars and across
select international markets.